A Study for Patients With Type 2 Diabetes Mellitus

NCT00490854 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

129

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Human Insulin Inhalation Powder
DRUG: Neutral protamine hagedorn insulin

Sponsor

Eli Lilly and Company

Collaborators

[object Object]